{"id":476815,"date":"2021-04-15T08:04:17","date_gmt":"2021-04-15T12:04:17","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\/"},"modified":"2021-04-15T08:04:17","modified_gmt":"2021-04-15T12:04:17","slug":"biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\/","title":{"rendered":"BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Therapy Developer"},"content":{"rendered":"<div class=\"xn-newslines\">\n<h2 class=\"xn-hedline\">Product Fills Critical Cold Chain Need to Enable High Volume Production of Allogeneic Cell Therapies<\/h2>\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">BOTHELL, Wash.<\/span>, <span class=\"xn-chron\">April 15, 2021<\/span> \/PRNewswire\/ &#8212; <b><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3129983-1&amp;h=2249249691&amp;u=http%3A%2F%2Fwww.biolifesolutions.com%2F&amp;a=BioLife+Solutions%2C+Inc.+\" rel=\"nofollow noopener\">BioLife Solutions, Inc. <\/a><\/b>(NASDAQ: BLFS)\u00a0(&#8220;BioLife&#8221; or the &#8220;Company&#8221;), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced that it has launched a new line of high capacity controlled rate freezers (HCRF), with an initial shipment to a leading cell therapy company. The freezer will be a critical component in this customer&#8217;s cold chain management of several allogeneic cell therapies in development.\u00a0 \u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1488310\/BioLife.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1488310\/BioLife.jpg\" title=\"BioLife's CBS High Capacity Rate Freezer\" alt=\"BioLife's CBS High Capacity Rate Freezer\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <span class=\"xn-person\">Todd Berard<\/span>, BioLife&#8217;s Chief Marketing Officer, commented, &#8220;This product launch expands our Cryogenic Freezer Platform with high capacity controlled rate freezers designed specifically to meet the needs of cell and gene therapy developers.\u00a0 We&#8217;re very pleased to support this and several other pending customers by providing a critical cold chain management platform to protect their high value biologic materials that require precise control of the critical freezing process and subsequent frozen storage.&#8221;<\/p>\n<p>Key features and benefits of the High Capacity Rate Freezer product line include:<\/p>\n<ul type=\"disc\">\n<li>\n          <b>Large Volume Freezing &#8211; <\/b>Capacity to freeze up to several thousand cryovials or several hundred cryobags in cassettes in one run, saving time and ensuring consistency in freeze runs. <\/li>\n<li>\n          <b>Quality Assurance Data Management &#8211; <\/b>Ability to chart samples by chamber and program temperature to ensure freeze run consistency. <\/li>\n<li>\n          <b>Touch Screen Controller &#8211; <\/b>Includes 6 pre-set run programs and the option to create custom freeze run profiles. <\/li>\n<li>\n          <b>Multiple Fan and Probe Design &#8211; <\/b>Ensures uniform temperature within the payload cavity. <\/li>\n<li>\n          <b>Precision Control \u2013<\/b> Temperature range of -180 to + 50\u00b0C, with freeze rates of 0.01 to 99.9\u00b0C per minute. <\/li>\n<li>\n          <b>Innovative Racking Systems \u2013 <\/b>Enables flexible and efficient payload loading and storage. <\/li>\n<li>\n          <b>Reduced operating cost \u2013<\/b> Less liquid nitrogen required vs. competing products.<\/li>\n<\/ul>\n<p>\n        <span class=\"xn-person\">Roderick de Greef<\/span>, Chief Financial and Operating Officer at BioLife Solutions, remarked, &#8220;The team at CBS has worked hard to complete the design, manufacturing and validation of this new and differentiated controlled rate freezer. We have said that new product introductions are key to driving gross margin expansion within our freezer line, and this is a step toward that goal, as we expect unit gross margins on this product family in the mid to high 50% range, with average selling prices in the <span class=\"xn-money\">$450,000<\/span> to <span class=\"xn-money\">$750,000<\/span> range.<\/p>\n<p>\n        <b>About BioLife Solutions<\/b>\n      <\/p>\n<p>BioLife Solutions is a leading supplier of class-defining cell and gene therapy bioproduction tools and services. Our tools portfolio includes our proprietary\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3129983-1&amp;h=416750166&amp;u=https%3A%2F%2Fwww.biolifesolutions.com%2Fproduct-category%2Fcryostor%2F&amp;a=CryoStor\" rel=\"nofollow noopener\">CryoStor<\/a><sup>\u00ae<\/sup><sup>\u00a0<\/sup>freeze media and <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3129983-1&amp;h=811453530&amp;u=https%3A%2F%2Fwww.biolifesolutions.com%2Fproduct-category%2Fhypothermosol%2F&amp;a=HypoThermosol\" rel=\"nofollow noopener\">HypoThermosol<\/a><sup>\u00ae<\/sup>\u00a0shipping and storage media, <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3129983-1&amp;h=3158155820&amp;u=https%3A%2F%2Fwww.biolifesolutions.com%2Fproduct-category%2Fthawstar%2F&amp;a=ThawSTAR\" rel=\"nofollow noopener\">ThawSTAR<\/a><sup>\u00ae<\/sup>\u00a0family of automated, water-free thawing products, <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3129983-1&amp;h=3449170431&amp;u=https%3A%2F%2Fwww.savsu.com%2F&amp;a=evo\" rel=\"nofollow noopener\">evo<\/a><sup>\u00ae<\/sup>\u00a0cold chain management system,\u00a0 <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3129983-1&amp;h=220393276&amp;u=https%3A%2F%2Fwww.custombiogenics.com%2F&amp;a=Custom+Biogenic+Systems\" rel=\"nofollow noopener\">Custom Biogenic Systems<\/a>\u00a0high capacity storage freezers and <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3129983-1&amp;h=3215506143&amp;u=http%3A%2F%2Fwww.scisafe.com%2F&amp;a=SciSafe\" rel=\"nofollow noopener\">SciSafe<\/a> biologic storage services. For more information, please visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3129983-1&amp;h=147718435&amp;u=http%3A%2F%2Fwww.biolifesolutions.com%2F&amp;a=www.biolifesolutions.com\" rel=\"nofollow noopener\">www.biolifesolutions.com<\/a>, and follow BioLife on <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3129983-1&amp;h=3509093662&amp;u=https%3A%2F%2Ftwitter.com%2Fbiolifesol&amp;a=Twitter\" rel=\"nofollow noopener\">Twitter<\/a>. <\/p>\n<p>\n        <b>Cautions Regarding Forward Looking Statements <\/b>\n      <\/p>\n<p>\n        <i>Except for historical information contained herein, this press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements concerning the expected performance of the Company&#8217;s high capacity controlled rate freezers, the demand for and impact of the high capacity controlled rate freezers for the Company&#8217;s customers, the average sale price and gross margin of the high capacity controlled rate freezers, and the impact on gross margin of the high capacity controlled rate freezers on the Company&#8217;s freezer line of products generally. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These statements are based on management&#8217;s current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including among other things, uncertainty regarding unexpected costs associated with the production or scaling up of production of the high capacity controlled rate freezers, market adoption of the high capacity controlled rate freezers specifically or the company&#8217;s suite of products generally, the ability of the company to implement its business strategy, uncertainty regarding third-party market projections, market volatility, competition, litigation, the impact of the COVID-19 pandemic, and those other factors described in our risk factors set forth in our filings with the Securities and Exchange Commission from time to time, including our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. We undertake no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable law.<\/i>\u00a0<\/p>\n<p>\n        <b>Media &amp; Investor Relations<br \/><\/b><br \/>\n        <span class=\"xn-person\">Roderick de Greef<\/span><br \/>\n        <br \/>Chief Financial Officer &amp; Chief Operating Officer<br \/>(425) 686-6002 <br \/><a target=\"_blank\" href=\"mailto:rdegreef@biolifesolutions.com\" rel=\"nofollow noopener\">rdegreef@biolifesolutions.com<\/a><\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/464869\/BioLife_Solutions.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/464869\/BioLife_Solutions.jpg\" title=\"Cell and gene therapy tools. (PRNewsfoto\/BioLife Solutions, Inc.)\" alt=\"Cell and gene therapy tools. (PRNewsfoto\/BioLife Solutions, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA43546&amp;sd=2021-04-15\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer-301269417.html\">http:\/\/www.prnewswire.com\/news-releases\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer-301269417.html<\/a><\/p>\n<p>SOURCE  BioLife Solutions, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LA43546&amp;Transmission_Id=202104150800PR_NEWS_USPR_____LA43546&amp;DateId=20210415\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Product Fills Critical Cold Chain Need to Enable High Volume Production of Allogeneic Cell Therapies PR Newswire BOTHELL, Wash., April 15, 2021 \/PRNewswire\/ &#8212; BioLife Solutions, Inc. (NASDAQ: BLFS)\u00a0(&#8220;BioLife&#8221; or the &#8220;Company&#8221;), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced that it has launched a new line of high capacity controlled rate freezers (HCRF), with an initial shipment to a leading cell therapy company. The freezer will be a critical component in this customer&#8217;s cold chain management of several allogeneic cell therapies in development.\u00a0 \u00a0 Todd Berard, BioLife&#8217;s Chief Marketing Officer, commented, &#8220;This product launch expands our Cryogenic Freezer Platform with high capacity controlled rate freezers designed &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Therapy Developer&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-476815","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Therapy Developer - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Therapy Developer - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Product Fills Critical Cold Chain Need to Enable High Volume Production of Allogeneic Cell Therapies PR Newswire BOTHELL, Wash., April 15, 2021 \/PRNewswire\/ &#8212; BioLife Solutions, Inc. (NASDAQ: BLFS)\u00a0(&#8220;BioLife&#8221; or the &#8220;Company&#8221;), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced that it has launched a new line of high capacity controlled rate freezers (HCRF), with an initial shipment to a leading cell therapy company. The freezer will be a critical component in this customer&#8217;s cold chain management of several allogeneic cell therapies in development.\u00a0 \u00a0 Todd Berard, BioLife&#8217;s Chief Marketing Officer, commented, &#8220;This product launch expands our Cryogenic Freezer Platform with high capacity controlled rate freezers designed &hellip; Continue reading &quot;BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Therapy Developer&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-15T12:04:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1488310\/BioLife.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Therapy Developer\",\"datePublished\":\"2021-04-15T12:04:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\\\/\"},\"wordCount\":797,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1488310\\\/BioLife.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\\\/\",\"name\":\"BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Therapy Developer - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1488310\\\/BioLife.jpg\",\"datePublished\":\"2021-04-15T12:04:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1488310\\\/BioLife.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1488310\\\/BioLife.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Therapy Developer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Therapy Developer - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\/","og_locale":"en_US","og_type":"article","og_title":"BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Therapy Developer - Market Newsdesk","og_description":"Product Fills Critical Cold Chain Need to Enable High Volume Production of Allogeneic Cell Therapies PR Newswire BOTHELL, Wash., April 15, 2021 \/PRNewswire\/ &#8212; BioLife Solutions, Inc. (NASDAQ: BLFS)\u00a0(&#8220;BioLife&#8221; or the &#8220;Company&#8221;), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced that it has launched a new line of high capacity controlled rate freezers (HCRF), with an initial shipment to a leading cell therapy company. The freezer will be a critical component in this customer&#8217;s cold chain management of several allogeneic cell therapies in development.\u00a0 \u00a0 Todd Berard, BioLife&#8217;s Chief Marketing Officer, commented, &#8220;This product launch expands our Cryogenic Freezer Platform with high capacity controlled rate freezers designed &hellip; Continue reading \"BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Therapy Developer\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-15T12:04:17+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1488310\/BioLife.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Therapy Developer","datePublished":"2021-04-15T12:04:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\/"},"wordCount":797,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1488310\/BioLife.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\/","name":"BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Therapy Developer - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1488310\/BioLife.jpg","datePublished":"2021-04-15T12:04:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1488310\/BioLife.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1488310\/BioLife.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biolife-solutions-launches-new-high-capacity-controlled-rate-freezer-line-with-first-shipment-to-a-leading-cell-therapy-developer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Therapy Developer"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/476815","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=476815"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/476815\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=476815"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=476815"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=476815"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}